Show Summary Details
Page of

Sympathectomy for cancer pain 

Sympathectomy for cancer pain
Sympathectomy for cancer pain

Dhanalakshmi Koyyalagunta

and Arun Bhaskar

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 September 2021

Abdominal and pelvic pain from malignancies can be debilitating and often a cause for significant distress and 52–60% of patients with gastrointestinal, urogenital, and gynaecological malignancies have abdominal pain. Treatment of the pain in these patients with cancer can be challenging and often refractory to pharmacological therapy adopting the World Health Organization ladder guidelines alone. Pain physicians have adopted the use of interventional modalities to optimize pain control at various stages of the disease. Visceral innervation of the abdomen and pelvis is from the coeliac plexus, superior, and the ganglion impar. Percutaneous neurolysis of the sympathetic chain can provide significant pain relief for cancer-related visceral pain syndromes. Interruption of the sympathetic nervous system with a neurolytic agent can be achieved at the coeliac, superior, and ganglion impar. This will help optimize pain control, decrease the opioid dose and associated side effects, and result in an improvement in quality of life. The anatomy of the sympathetic axis, the various sympathetic blocks, agents commonly used, and available evidence on efficacy of these blocks are outlined in this chapter.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.